Mitral Valve Catheter-Based Interventions: Auxiliary Techniques and Work in Progress

Chapter

Abstract

Mitral valve disease is the one of the most common of the valvular heart disorders, particularly in aging populations, with a prevalence of more than 10% in people aged more than 75 years [1]. Heart failure is one of the most frequent causes of functional mitral valve regurgitation (MR) [2]. Enriquez-Sarano and colleagues estimated that moderate to severe mitral regurgitation will double its prevalence by 2030, affecting more than 4 million people [1, 3]. Interestingly, MR is the second most common valve disease requiring surgery in Europe as most of the patients are managed conservatively [3]. MR is divided into either primary (a structural or degenerative abnormality of the mitral valve apparatus) or secondary (a disease of the left ventricle (LV) that interferes with the function and integrity of the mitral valve apparatus) MR [1, 3]. Mitral stenosis is usually due to rheumatic disease, but heavy calcification of the mitral leaflets might involve the subvalvar apparatus [1, 4].

References

  1. 1.
    Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–11.CrossRefPubMedGoogle Scholar
  2. 2.
    Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373:1382–94.CrossRefPubMedGoogle Scholar
  3. 3.
    lung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231–43.CrossRefGoogle Scholar
  4. 4.
    Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48:e1–e148.CrossRefPubMedGoogle Scholar
  5. 5.
    Di Salvo TG, Acker MA, Dec GW, Byrne JG. Mitral valve surgery in advanced heart failure. J Am Coll Cardiol. 2010;55:271–82.CrossRefPubMedGoogle Scholar
  6. 6.
    Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M. Guidelines on the management of valvular heart disease (version 2012): joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012;33:2451–96.CrossRefPubMedGoogle Scholar
  7. 7.
    Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Detaint D, Vanoverschelde JL, Butchart EG, Ravaud P, Vahanian A. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28:1358–65.CrossRefPubMedGoogle Scholar
  8. 8.
    Wunderlich NC, Siegel RJ. Peri-interventional echo assessment for the MitraClip procedure. Eur Heart J Cardiovasc Imaging. 2013;14:935–49.CrossRefPubMedGoogle Scholar
  9. 9.
    Anyanwu AC, Adams DH. Transcatheter mitral valve replacement: the next revolution? J Am Coll Cardiol. 2014;64:1820–4.CrossRefPubMedGoogle Scholar
  10. 10.
    Mauri L, Foster E, Glower DD, Apruzzese P, Massaro JM, Herrmann HC, Hermiller J, Gray W, Wang A, Pedersen WR, Bajwa T, Lasala J, Low R, Grayburn P, Feldman T, EVEREST II Investigators. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol. 2013;62:317–28.CrossRefPubMedGoogle Scholar
  11. 11.
    Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Sarris GE, Fann JI, Niczyporuk MA, Derby GC, Handen CE, Miller DC. Global and regional left ventricular systolic performance in the in situ ejecting canine heart. Importance of the mitral apparatus. Circulation. 1989;80(3 Pt 1):I24–42.PubMedGoogle Scholar
  13. 13.
    Timek TA, Green GR, Tibayan FA, Lai DT, Rodriguez F, Liang D, Daughters GT, Ingels NB Jr, Miller DC. Aorto-mitral annular dynamics. Ann Thorac Surg. 2003;76:1944–50.CrossRefPubMedGoogle Scholar
  14. 14.
    Ranganathan N, Lam JHC, Wigle ED, et al. Morphology of the human mitral valve II. The valve leaflets. Circulation. 1970;41:459–67.CrossRefPubMedGoogle Scholar
  15. 15.
    Roberts WC, Cohen LS. Left ventricular papillary muscles. Description of the normal and a survey of conditions causing them to be abnormal. Circulation. 1972;46:138–54.CrossRefPubMedGoogle Scholar
  16. 16.
    Ho S. Anatomy of the mitral valve. Heart. 2002;88:iv5–iv10.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Okamoto K, Kiso I, Inoue Y, Matayoshi H, Takahashi R, Umezu Y. Left ventricular outflow obstruction after mitral valve replacement preserving native anterior leaflet. Ann Thorac Surg. 2006;82:735–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Bapat V, Pirone F, Kapetanakis S, Rajani R, Niederer S. Factors influencing left ventricular outflow tract obstruction following a mitral valve-in-valve or valve-in-ring procedure, part 1. Catheter Cardiovasc Interv. 2015;86:747–60.CrossRefPubMedGoogle Scholar
  19. 19.
    Tang GH, George I, Hahn RT, Bapat V, Szeto WY, Kodali SK. Transcatheter mitral valve replacement: design implications, potential pitfalls and outcomes assessment. Cardiol Rev. 2015;23:290–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L, EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395–406.CrossRefPubMedGoogle Scholar
  21. 21.
    Colli A, Manzan E, Rucinskas K, Janusauskas V, Zucchetta F, Zakarkaitė D, Aidietis A, Gerosa G. Acute safety and efficacy of the NeoChord procedure. Interact Cardiovasc Thorac Surg. 2015;20:575–81.CrossRefPubMedGoogle Scholar
  22. 22.
    Schofer J, Siminiak T, Haude M, Herrman JP, Vainer J, Wu JC, Levy WC, Mauri L, Feldman T, Kwong RY, Kaye DM, Duffy SJ, Tubler T, Degen H, Brandt MC, Van Bibber R, Goldberg S, Reuter DG, Hoppe UC. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation. 2009;120:326–33.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Maisano F, La Canna G, Latib A, Denti P, Taramasso M, Kuck KH, Colombo A, Alfieri O, Guidotti A, Messika-Zeitoun D, Vahanian A. First-in-man transseptal implantation of a “surgicallike” mitral valve annuloplasty device for functional mitral regurgitation. JACC Cardiovasc Interv. 2014;7:1326–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Maisano F, Taramasso M. The Cardioband transcatheter direct mitral valve annuloplasty system. EuroIntervention. 2015;11(suppl W):W58–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Siminiak T, Wu JC, Haude M, Hoppe UC, Sadowski J, Lipiecki J, Fajadet J, Shah AM, Feldman T, Kaye DM, Goldberg SL, Levy WC, Solomon SD, Reuter DG. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN trial. Eur J Heart Fail. 2012;14:931–8.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Schueler R, Nickenig G. The Mitralign: strategies for optimal patient selection and optimised results. EuroIntervention. 2016;12(Y):Y67–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Rogers JH, Rahdert DA, Caputo GR, Takeda PA, Palacios IF, Tio FO, Taylor EA, Low RI. Long-term safety and durability of percutaneous septal sinus shortening (the PS(3) System) in an ovine model. Catheter Cardiovasc Interv. 2009;73(4):540–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Feldman T, Guerrero M, Salinger MH. Emerging technologies for direct and indirect percutaneous mitral annuloplasty. EuroIntervention. 2016;12(Y):Y84–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Gooley RP, Meredith IT. The Accucinch transcatheter direct mitral valve annuloplasty system. EuroIntervention. 2015;11(Suppl W):W60–1.CrossRefPubMedGoogle Scholar
  30. 30.
    Colli A, Manzan E, Zucchetta F, Bizzotto E, Besola L, Bagozzi L, Bellu R, Sarais C, Pittarello D, Gerosa G. Transapical off-pump mitral valve repair with Neochord implantation: early clinical results. Int J Cardiol. 2016;204:23–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Al-Atassi T, Thourani VH. Transapical beating-heart mitral valve repair using a cordal implantation device-are we ready to open our minds? Ann Transl Med. 2016;4(Suppl 1):S17.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Gammie JS, Wilson P, Bartus K, Gackowski A, Hung J, D'Ambra MN, Kolsut P, Bittle GJ, Szymanski P, Sadowski J, Kapelak B, Bilewska A, Kusmierczyk M, Ghoreishi M. Transapical beating-heart mitral valve repair with an expanded polytetrafluoroethylene cordal implantation device: initial clinical experience. Circulation. 2016;134(3):189–97.CrossRefPubMedGoogle Scholar
  33. 33.
    Maisano F, Alfieri O, Banai S, et al. The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? Eur Heart J. 2015;36:1651–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Nishimura RA, Vahanian A, Eleid MF, Mack MJ. Mitral valve disease--current management and future challenges. Lancet. 2016;387(10025):1324–34.CrossRefPubMedGoogle Scholar
  35. 35.
    Chiam PT, Ruiz CE. Percutaneous transcatheter mitral valve repair: a classification of the technology. JACC Cardiovasc Interv. 2011;4(1):1–13.CrossRefPubMedGoogle Scholar
  36. 36.
    Schueler R, Öztürk C, Wedekind JA, Werner N, Stöckigt F, Mellert F, Nickenig G, Hammerstingl C. Persistence of iatrogenic atrial septal defect after interventional mitral valve repair with the MitraClip system: a note of caution. JACC Cardiovasc Interv. 2015;8:450–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Cheung A, Webb JG, Wong DR, Ye J, Masson JB, Carere RG, Lichtenstein SV. Transapical transcatheter mitral valve-in-valve implantation in a human. Ann Thorac Surg. 2009;87:e18–20.CrossRefPubMedGoogle Scholar
  38. 38.
    Piazza N, Treede H, Moat N, Sorajja P, Popma J, Grube E, Bolling S, Adams D. The Medtronic transcatheter mitral valve implantation system. EuroIntervention. 2015;11:W80–1.CrossRefPubMedGoogle Scholar
  39. 39.
    Sondergaard L, Ussia GP, Dumonteil N, Quadri A. The CardiAQ™ transcatheter mitral valve implantation system. EuroIntervention. 2015;11:W76–7.CrossRefPubMedGoogle Scholar
  40. 40.
    Al-Lawati A, Cheung A. Transcatheter mitral valve replacement. Int Cardiol Clin. 2016;1:109–15.  https://doi.org/10.1016/j.iccl.2015.08.010 Google Scholar
  41. 41.
    Ussia GP, Quadri A, Cammalleri V, De Vico P, Muscoli S, Marchei M, Ruvolo G, Sondergaard L, Romeo F. Percutaneous transseptal-transfemoral implantation of second generation CardiAQ™ mitral valve bioprosthesis: first procedure description and 30-day follow-up. EuroIntervention. 2015;11(5). pii: EIJ-D-15-00080. doi: https://doi.org/10.4244/EIJY15M09_01.CrossRefPubMedGoogle Scholar
  42. 42.
    Bapat V, Lim Z, Boix R, Pirone F. The Edwards Fortis transcatheter mitral valve implantation system. EuroIntervention. 2015;11:W73–5.CrossRefPubMedGoogle Scholar
  43. 43.
    Verheye S, Cheung A, Leon M, Banai S. The Tiara transcatheter mitral valve implantation system. EuroIntervention. 2015;11:W71–2.CrossRefPubMedGoogle Scholar
  44. 44.
    Cheung A, Webb J, Verheye S, Moss R, Boone R, Leipsic J, Ree R, Banai S. Short-term results of transapical mitral valve implantation for mitral regurgitation. J Am Coll Cardiol. 2014;64:1814–9.CrossRefPubMedGoogle Scholar
  45. 45.
    Perpetua E, Reisman M. The Tendyne transcatheter mitral valve implantation system. EuroIntervention. 2015;11:W78–9.CrossRefPubMedGoogle Scholar
  46. 46.
    Muller D. Transcatheter mitral valve replacement: new valves and experiences. In: Euro PCR Meeting. Paris, France 2015.Google Scholar
  47. 47.
    Meredith I, Bapat V, Morriss J, McLean M, Prendergast B. Intrepid transcatheter mitral valve replacement system: technical and product description. EuroIntervention. 2016;12(Y):Y78–80.CrossRefPubMedGoogle Scholar
  48. 48.
    Lange R, Piazza N. HighLife transcatheter mitral valve replacement. EuroIntervention. 2016;12:Y81–3.CrossRefPubMedGoogle Scholar
  49. 49.
    Krishnaswamy A, Mick S, Navia J, Gillinov AM, Tuzcu EM, Kapadia SR. Transcatheter mitral valve replacement: a frontier in cardiac intervention. Cleve Clin J Med. 2016;83(11 Suppl 2):S10–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Interventional CardiologyThe Heart Center, Rigshospitalet, Copenhagen University HospitalCopenhagenDenmark
  2. 2.Department of Cardiovascular SurgeryColumbia University Medical CenterNew YorkUSA

Personalised recommendations